China to India: Ras Import Trade Route

The China to India Ras corridor is one of India's established pharmaceutical import routes from China, with 277 shipments documented worth a combined $9.5M USD. The route is dominated by SMITH & NEPHEW ASIA PACIFIC PTE. LIMITED , which alone accounts for roughly 61% of all import value, reflecting the consolidated nature of China's ras export sector.

Across 28 active China suppliers, the average shipment value stands at $34.2K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Sea freight dominates at 81% of all shipments, consistent with ras's non-urgent bulk-order profile.

Shipment activity peaks during July–September, with an average transit time of 34 days port-to-port. The route has recorded an annual growth rate of 22.6%, placing it at rank #9 among India's top ras import origins globally.

On the Indian buyer side, key Indian importers include SMITH & NEPHEW HEALTHCARE PRIVATE LIMITED , INTAS PHARMACEUTICALS LIMITED , INTAS PHARMACEUTICALS LIMITED and 20 others. SMITH & NEPHEW HEALTHCARE PRIVATE LIMITED is the single largest Indian importer with 95 shipments valued at $5.8M USD.

India's ras imports from China are driven primarily by a handful of large-scale China manufacturers. SMITH & NEPHEW ASIA PACIFIC PTE. LIMITED with 94 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 28 active exporters signals a competitive but concentrated market — Indian buyers benefit from China supplier diversity while the top tier handles the majority of volume.

The top 3 suppliers — SMITH & NEPHEW ASIA PACIFIC PTE. LIMITED , SHANGHAI HENLIUS BIOPHARMACEUTICAL CO., LTD , SHANGHAI HENLIUS BIOPHARMACEUTICAL CO., LTD — together account for 86% of total trade value on this route. The average shipment value of $34.2K USD reflects a mix of bulk commercial orders and smaller specialty shipments.

Beyond the primary product category, shipments on this route include closely related formulations such as 7311 adhesive surgical dressing - intrasite gel applipak 15gctn 10 and trasutuzumab (active substance in trasutuzumab drug substance) , suggesting that Indian buyers tend to consolidate orders across related product lines from the same China supplier.

On the buying side, SMITH & NEPHEW HEALTHCARE PRIVATE LIMITED is the largest importer with 95 shipments worth $5.8M USD — representing 62% of all ras imports from China on this route. A total of 23 buyers are active on this corridor.